Compare Oscar Health Inc (OSCR) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Weibo Corp — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Weibo Corp trades at $6.54 (market cap $1.56B). The key difference: Oscar Health Inc is far larger — about 6.6× Weibo Corp's market cap, and Weibo Corp pays a 9.47% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Weibo Corp for 102 Days on average.
| OSCR | WB | |
|---|---|---|
Market Cap | $10.22B | $1.56B |
Volume | 4,123,394 | 812,503 |
Sector | Health | Media |
52-Week High | $33.81 | $12.37 |
52-Week Low | $10.85 | $6.33 |
Typical Hold Time | 15 Days | 102 Days |
Enterprise Value | $6.57B | $786.69M |
Dividend Yield | — | 9.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Weibo (WB) trades at $6.54, up 0.93% with bearish technical signals despite attractive valuation metrics including a P/E of 5.32 and P/B of 0.4. The company reported mixed Q2 2026 earnings with a beat on EPS but faces declining user metrics and advertising challenges. Net cash flow turned negative in 2024 at -$694M before recovering to $408M in 2025, while revenue has remained stagnant around $1.8B annually.
WB presents as a deep-value play with strong profitability margins but limited growth visibility. The stock's upside depends on advertising recovery and user engagement stabilization, though competitive pressures and China's regulatory environment pose significant risks. Analyst consensus is divided with 41% buy ratings, reflecting uncertainty about the company's ability to reignite growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
